DXP Enterprises (DXPE): Insider Notice to Sell 6,000 Shares ($718,680)

DXP Enterprises (DXPE) Form 144 summary: An individual intends to sell 6,000 common shares through UBS Financial Services, with an aggregate market value of $718,680.

Rhea-AI Filing Summary

DXP Enterprises (DXPE) Form 144 summary: An individual intends to sell 6,000 common shares through UBS Financial Services, with an aggregate market value of $718,680. The proposed sale is listed for 08/13/2025 and the issuer's outstanding shares are reported as 15,694,084, so the block represents roughly 0.038% of outstanding stock.

The 6,000 shares correspond to specific ESPP purchases between 2016 and 2024 (lots of 418, 674, 134, 2,906, 104 and 1,764 shares). The filer reports "Nothing to Report" for securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.

Insights

Financial Analyst

TL;DR: Proposed sale of 6,000 DXPE shares is immaterial to the float and likely neutral for market impact.

The filing shows a planned disposition of 6,000 common shares valued at $718,680, representing about 0.038% of 15,694,084 outstanding shares. The shares were acquired through the company's ESPP across multiple dates from 2016 to 2024, indicating routine employee plan sales rather than concentrated insider divestiture. Impact assessment: not impactful for valuation or liquidity based on size alone.

Corporate Governance Expert

TL;DR: Form 144 documents routine ESPP-derived sales via UBS; no governance red flags evident in this filing.

The notice lists the broker as UBS and documents the specific ESPP lots being sold, with no reported sales in the prior three months. The filer also affirms the standard statement about lacking undisclosed material adverse information. From a governance perspective this is a routine disclosure of a proposed sale with no immediate material governance concerns. Impact assessment: not impactful.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DXPE Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 6,000 common shares through UBS Financial Services with an aggregate market value of $718,680.

When is the approximate date of sale listed on the Form 144 for DXPE?

The Form 144 lists an approximate date of sale of 08/13/2025.

How much of DXPE's outstanding stock does the proposed sale represent?

The filing shows 15,694,084 shares outstanding, so 6,000 shares equal about 0.038% of outstanding shares.

How were the shares being sold originally acquired?

All 6,000 shares were acquired under the issuer's ESPP in lots dated between 2016 and 2024 (specific lot sizes are listed in the filing).

Does the filer report any securities sold in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2025 - 05:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001379062
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DXP Enterprises, Inc
SEC File Number	000-21513
Address of Issuer	5301 Hollister Houston TEXAS 77040
Phone	713-996-4700
Name of Person for Whose Account the Securities are To Be Sold	John J Jeffery
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	6000	718680	15694084	08/13/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/31/2024	ESPP	Issuer			1764	03/31/2024	Cash
Common	08/11/2016	ESPP	Issuer			418	08/11/2016	Cash
common	03/22/2017	ESPP	Issuer			674	03/22/2017	Cash
Common	04/05/2017	ESPP	Issuer			134	04/05/2017	cash
Common	08/14/2017	ESPP	Issuer			2906	08/14/2017	Cash
Common	03/10/2018	ESPP	Issuer			104	03/10/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for John J Jeffery
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)